Anzeige
Meldung des Tages: +45 % in einem Monat, Gas über 54 Euro: Beginnt jetzt die nächste Phase bei CanCambria?

Jazz Pharmaceuticals News

Aktie
WKN:  A1JS1K ISIN:  IE00B4Q5ZN47 US-Symbol:  JAZZ Branche:  Biotechnologie Land:  Irland
179,57 $
-0,91 $
-0,50%
155,95 € 16:20:54 Uhr
Depot/Watchlist
Marktkapitalisierung *
8,78 Mrd. €
Streubesitz
-
KGV
-
Nachhaltigkeits-Score
37 %
Index-Zuordnung
-
Weiter abwärts? Short handeln - Jetzt mit Hebel 5,24: JU6CB1
Werbung

Jazz Pharmaceuticals News

02.06.25 - PR Newswire
Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-hrii) in First-Line HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ASCO 2025
Jazz Pharmaceuticals Reports Clinically Meaningful Long-Term Median Overall Survival Data for Ziihera® (zanidatamab-​hrii) in First-​Line HER2-Positive Metastatic ...
29.05.25 - PR Newswire
Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) in Sleep Conditions and Associated Comorbidities at SLEEP 2025
Jazz Pharmaceuticals to Present Expansive Research Demonstrating Comprehensive Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) in ...
21.05.25 - PR Newswire
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire
21.05.25 - PR Newswire
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences PR Newswire
06.05.25 - PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance PR Newswire
06.05.25 - PR Newswire
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance
Jazz Pharmaceuticals Announces First Quarter 2025 Financial Results and Updates 2025 Financial Guidance PR Newswire
30.04.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference PR Newswire
30.04.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference
Jazz Pharmaceuticals to Participate in the BofA Securities 2025 Healthcare Conference PR Newswire
25.04.25 - PR Newswire
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer
Jazz Pharmaceuticals Receives CHMP Positive Opinion for Zanidatamab for the Treatment of Advanced HER2-Positive Biliary Tract Cancer PR Newswire
23.04.25 - PR Newswire
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma
Jazz Pharmaceuticals Showcases Transformative Data at ASCO 2025, Highlighting Advances in Small Cell Lung Cancer, HER2+ Gastroesophageal Cancer and Diffuse Glioma PR ...
22.04.25 - PR Newswire
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 PR Newswire
22.04.25 - PR Newswire
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 6, 2025 PR Newswire
21.04.25 - PR Newswire
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire
21.04.25 - PR Newswire
Jazz Pharmaceuticals Completes Acquisition of Chimerix
Jazz Pharmaceuticals Completes Acquisition of Chimerix PR Newswire
26.03.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
26.03.25 - PR Newswire
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference
Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference PR Newswire
19.03.25 - PR Newswire
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® (cannabidiol) at American Academy of Neurology Annual Meeting
Jazz Pharmaceuticals to Showcase Research Demonstrating Treatment Benefits of Xywav® (calcium, magnesium, potassium, and sodium oxybates) Oral Solution and Epidiolex® ...

Newssuche

Videos

newspaper
15:00 Uhr
COUNTER HUNTER Strategie Einführung
Live-​Seminar am 29.3. ab 14 Uhr! Wie immer wird die Schulung auch aufgezeichnet und allen ... Mehr »